Literature DB >> 26637970

Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.

Denada Dibra1, Xueqing Xia1, Abhisek Mitra1, Jeffry J Cutrera1, Guillermina Lozano2, Shulin Li1.   

Abstract

UNLABELLED: The cellular and molecular etiology of unresolved chronic liver inflammation remains obscure. Whereas mutant p53 has gain-of-function properties in tumors, the role of this protein in liver inflammation is unknown. Herein, mutant p53(R172H) is mechanistically linked to spontaneous and sustained liver inflammation and steatosis when combined with the absence of interleukin-27 (IL27) signaling (IL27RA), resembling the phenotype observed in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) patients. Indeed, these mice develop, with age, hepatocyte necrosis, immune cell infiltration, fibrosis, and micro- and macrosteatosis; however, these phenotypes are absent in mutant p53(R172H) or IL27RA(-/-) mice. Mechanistically, endothelin A receptor (ETAR)-positive macrophages are highly accumulated in the inflamed liver, and chemical inhibition of ETAR signaling reverses the observed phenotype and negatively regulates mutant p53 levels in macrophages.
CONCLUSION: The combination of mutant p53 and IL27RA(-/-) causes spontaneous liver inflammation, steatosis, and fibrosis in vivo, whereas either gene alone in vivo has no effects on the liver.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26637970      PMCID: PMC4764463          DOI: 10.1002/hep.28379

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  35 in total

1.  Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes.

Authors:  Monika Julia Wolf; Arlind Adili; Kira Piotrowitz; Zeinab Abdullah; Yannick Boege; Kerstin Stemmer; Marc Ringelhan; Nicole Simonavicius; Michèle Egger; Dirk Wohlleber; Anna Lorentzen; Claudia Einer; Sabine Schulz; Thomas Clavel; Ulrike Protzer; Christoph Thiele; Hans Zischka; Holger Moch; Matthias Tschöp; Alexei V Tumanov; Dirk Haller; Kristian Unger; Michael Karin; Manfred Kopf; Percy Knolle; Achim Weber; Mathias Heikenwalder
Journal:  Cancer Cell       Date:  2014-10-13       Impact factor: 31.743

Review 2.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

3.  Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis.

Authors:  Atsushi Yamanaka; Shinjiro Hamano; Yoshiyuki Miyazaki; Kazunari Ishii; Atsunobu Takeda; Tak W Mak; Kunisuke Himeno; Akihiko Yoshimura; Hiroki Yoshida
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

4.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Shiqi Yang; Huizhi Lin; Jiawen Huang; Paul A Watkins; Ann B Moser; Claudio Desimone; Xiao-yu Song; Anna Mae Diehl
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

5.  Defining stem cell dynamics in models of intestinal tumor initiation.

Authors:  Louis Vermeulen; Edward Morrissey; Maartje van der Heijden; Anna M Nicholson; Andrea Sottoriva; Simon Buczacki; Richard Kemp; Simon Tavaré; Douglas J Winton
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

6.  Liver p53 expression in patients with HCV-related chronic hepatitis.

Authors:  C Loguercio; A Cuomo; C Tuccillo; P Gazzerro; M Cioffi; A M Molinari; C Del Vecchio Blanco
Journal:  J Viral Hepat       Date:  2003-07       Impact factor: 3.728

Review 7.  Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship.

Authors:  Denada Dibra; Lopa Mishra; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-05-09

8.  Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.

Authors:  Vladislava O Melnikova; Annette B Santamaria; Svetlana V Bolshakov; Honnavara N Ananthaswamy
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

9.  IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice.

Authors:  Abhisek Mitra; Arun Satelli; Jun Yan; Xia Xueqing; Mihai Gagea; Christopher A Hunter; Lopa Mishra; Shulin Li
Journal:  Hepatology       Date:  2014-10-28       Impact factor: 17.298

10.  Non-cell-autonomous tumor suppression by p53.

Authors:  Amaia Lujambio; Leila Akkari; Janelle Simon; Danielle Grace; Darjus F Tschaharganeh; Jessica E Bolden; Zhen Zhao; Vishal Thapar; Johanna A Joyce; Valery Krizhanovsky; Scott W Lowe
Journal:  Cell       Date:  2013-04-04       Impact factor: 41.582

View more
  16 in total

1.  Endothelin-1 differentially directs lineage specification of adipose- and bone marrow-derived mesenchymal stem cells.

Authors:  Ming-Song Lee; Jesse Wang; Huihua Yuan; Hongli Jiao; Tsung-Lin Tsai; Matthew W Squire; Wan-Ju Li
Journal:  FASEB J       Date:  2018-08-10       Impact factor: 5.191

Review 2.  Genetic and epigenetic regulation of intestinal fibrosis.

Authors:  Chao Li; John F Kuemmerle
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

Review 3.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

4.  IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.

Authors:  Turan Aghayev; Aleksandra M Mazitova; Jennifer R Fang; Sergei I Grivennikov; Ekaterina K Koltsova; Iuliia O Peshkova; Matthew Rausch; Manhsin Hung; Kerry F White; Ricard Masia; Elizaveta K Titerina; Aliia R Fatkhullina; Isabelle Cousineau; Simon Turcotte; Dmitry Zhigarev; Anastasiia Marchenko; Svetlana Khoziainova; Petr Makhov; Yin Fei Tan; Andrew V Kossenkov; David L Wiest; John Stagg; Xin Wei Wang; Kerry S Campbell; Amiran K Dzutsev; Giorgio Trinchieri; Jonathan A Hill
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

5.  WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression.

Authors:  Man Wu; Xueqing Xia; Jiemiao Hu; Natalie Wall Fowlkes; Shulin Li
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919

6.  IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.

Authors:  Hitoshi Nishizawa; Genzo Iguchi; Hidenori Fukuoka; Michiko Takahashi; Kentaro Suda; Hironori Bando; Ryusaku Matsumoto; Kenichi Yoshida; Yukiko Odake; Wataru Ogawa; Yutaka Takahashi
Journal:  Sci Rep       Date:  2016-10-10       Impact factor: 4.379

Review 7.  Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.

Authors:  Yan Cui; Gang Guo
Journal:  Int J Mol Sci       Date:  2016-11-19       Impact factor: 5.923

Review 8.  Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family.

Authors:  Hideaki Hasegawa; Izuru Mizoguchi; Yukino Chiba; Mio Ohashi; Mingli Xu; Takayuki Yoshimoto
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

Review 9.  Role of nonresolving inflammation in hepatocellular carcinoma development and progression.

Authors:  Le-Xing Yu; Yan Ling; Hong-Yang Wang
Journal:  NPJ Precis Oncol       Date:  2018-02-23

Review 10.  Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.

Authors:  Miljana Nenkov; Yunxia Ma; Nikolaus Gaßler; Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.